Biologic Treatment Options for Retinal Neovascularization in Behçet’s Disease-Reference-Cited by-同舟云学术

Biologic Treatment Options for Retinal Neovascularization in Behçet’s Disease

Published:2017-07-12 Issue:1 Volume:27 Page:51-57
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Markomichelakis Nikos N.¹,Aissopou Evaggelia K.²,Maselos Stelios¹,Tugal-Tutkun Ilknur³,Sfikakis Petros P.²

Affiliation:

1. Ocular Inflammation/Immunology Service, Genimatas General Hospital, Athens, Greece

2. First Department of Propaedeutic Internal Medicine & Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, Medical School, Athens, Greece

3. Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2017.1332228

Reference45 articles.

1. Behçet's Disease

2. Immunopathology of the Noninfectious Posterior and Intermediate Uveitides

3. The Rate of Visual Loss in Behcet's Disease

4. Uveitis in Behçet disease: An analysis of 880 patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data;BioDrugs;2023-06-29

2. Anti-tumor necrosis factor-alpha therapy for refractory uveitic optic disk neovascularization in active non-infectious posterior and panuveitis;International Ophthalmology;2021-06-24

3. Clinical features, visual outcome, and poor prognostic factors in occlusive retinal vasculitis;Canadian Journal of Ophthalmology;2021-04

4. Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features;Ocular Immunology and Inflammation;2020-10-06

5. LncRNAs in ocular neovascularizations;International Journal of Ophthalmology;2019-12-18